1. Home
  2. SLN vs FNLC Comparison

SLN vs FNLC Comparison

Compare SLN & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • FNLC
  • Stock Information
  • Founded
  • SLN 1994
  • FNLC 1864
  • Country
  • SLN United Kingdom
  • FNLC United States
  • Employees
  • SLN N/A
  • FNLC N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • FNLC Major Banks
  • Sector
  • SLN Health Care
  • FNLC Finance
  • Exchange
  • SLN Nasdaq
  • FNLC Nasdaq
  • Market Cap
  • SLN 223.4M
  • FNLC 284.1M
  • IPO Year
  • SLN N/A
  • FNLC 1999
  • Fundamental
  • Price
  • SLN $4.23
  • FNLC $24.53
  • Analyst Decision
  • SLN Buy
  • FNLC
  • Analyst Count
  • SLN 5
  • FNLC 0
  • Target Price
  • SLN $40.80
  • FNLC N/A
  • AVG Volume (30 Days)
  • SLN 282.3K
  • FNLC 20.4K
  • Earning Date
  • SLN 02-27-2025
  • FNLC 04-16-2025
  • Dividend Yield
  • SLN N/A
  • FNLC 5.81%
  • EPS Growth
  • SLN N/A
  • FNLC N/A
  • EPS
  • SLN N/A
  • FNLC 2.43
  • Revenue
  • SLN $43,258,000.00
  • FNLC $79,740,000.00
  • Revenue This Year
  • SLN N/A
  • FNLC N/A
  • Revenue Next Year
  • SLN N/A
  • FNLC N/A
  • P/E Ratio
  • SLN N/A
  • FNLC $10.20
  • Revenue Growth
  • SLN 36.71
  • FNLC 0.35
  • 52 Week Low
  • SLN $4.06
  • FNLC $21.77
  • 52 Week High
  • SLN $27.72
  • FNLC $31.05
  • Technical
  • Relative Strength Index (RSI)
  • SLN 41.17
  • FNLC 35.02
  • Support Level
  • SLN $4.10
  • FNLC $25.36
  • Resistance Level
  • SLN $5.23
  • FNLC $26.38
  • Average True Range (ATR)
  • SLN 0.40
  • FNLC 0.58
  • MACD
  • SLN 0.06
  • FNLC -0.10
  • Stochastic Oscillator
  • SLN 33.90
  • FNLC 0.00

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

Share on Social Networks: